Patent · US Active

Low concentration meloxicam tablets

US9795568B2 · kind B2 · utility

1Cited by
49References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 26, 2011
Grant dateOct 24, 2017
Priority date
Expiry dateNov 12, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/5415
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to a solid tablet that is directly-compressed of powder, comprising meloxicam and one or more excipients which are homogenously dispersed within the tablet that can be broken into two, three or four units with each unit containing equal amounts of the active ingredient, meloxicam.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.